{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:50:50Z","timestamp":1770990650465,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier","isbn-type":[{"value":"9780323461429","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/b978-0-323-46142-9.00030-x","type":"book-chapter","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T20:16:35Z","timestamp":1488658595000},"page":"811-843","source":"Crossref","is-referenced-by-count":24,"title":["Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs\/NLCs)"],"prefix":"10.1016","author":[{"given":"Slavomira","family":"Doktorovova","sequence":"first","affiliation":[]},{"given":"Ranjita","family":"Shegokar","sequence":"additional","affiliation":[]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Abu Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0015","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/17425247.2014.935335","article-title":"Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals","volume":"11","author":"Aburahma","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2015.04.017","article-title":"Surface modification and local orientations of surface molecules in nanotherapeutics","volume":"207","author":"Amin","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2014.02.038","article-title":"A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases","volume":"456","author":"Apaolaza","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0030","series-title":"Crystalization Processes in Fats and Lipid Systems","article-title":"Fundamental aspects of equilibrium and crystallization kinetics","author":"Aquilano","year":"2001"},{"issue":"7","key":"10.1016\/B978-0-323-46142-9.00030-X_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40005-015-0182-3","article-title":"Comparison of solid lipid nanoparticles for encapsulating paclitaxel or docetaxel","volume":"45","author":"Baek","year":"2015","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0040","unstructured":"BASF, 2013. BASF\u2014Nutrition & Health Kolliphor P Grades. Technical Information leaflet. pp. 1\u20138."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.colsurfb.2013.04.021","article-title":"Lipid nanoparticles for brain targeting II. Technological characterization","volume":"110","author":"Blasi","year":"2013","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2005.06.004","article-title":"Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles","volume":"107","author":"Bunjes","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0055","series-title":"Processes in Fats and Lipid Systems","first-page":"177","article-title":"Influences of colloidal state on physical properties of solid fats","author":"Bunjes","year":"2001"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-5173(95)04286-5","article-title":"Crystallization tendency and polymorphic transitions in triglyceride nanoparticles","volume":"129","author":"Bunjes","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0065","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1021\/la990856l","article-title":"Effect of particle size on colloidal solid triglycerides","volume":"16","author":"Bunjes","year":"2000","journal-title":"Langmuir"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0070","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1021\/la062904p","article-title":"Visualizing the structure of triglyceride nanoparticles in different crystal modifications","volume":"23","author":"Bunjes","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9015","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/01932691.2010.498248","article-title":"Improved ex vivo transcutaneous permeation of diclofenac from solid lipid nanoparticles in the presence of novel long-chain alkyl esters of PABA","volume":"32","author":"Chandra Shekhar","year":"2011","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijpharm.2006.01.042","article-title":"Lecithin-based cationic nanoparticles as a potential DNA delivery system","volume":"313","author":"Cui","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9020","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s11095-012-0789-2","article-title":"Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application","volume":"29","author":"Desai","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2008.07.034","article-title":"Development of Chitosan\u2013SLN Microparticles for chemotherapy: In vitro approach through ef\ufb02ux-transporter modulation","volume":"131","author":"Dharmala","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1517\/17425240802712590","article-title":"Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a\u00a0comprehensive review","volume":"6","author":"Doktorovova","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.08.042","article-title":"Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies","volume":"420","author":"Doktorovova","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0095","unstructured":"Doktorovova, S., Jansch, M., Shegokar, R., Macedo, A., Martins-Lopes, P., Silva, A.M., Lopes, C.M., M\u00fcller, R.H., Souto, E.B., 2012a. Qualitative analysis of protein adsorption pattern on cationic solid lipid nanoparticles. 8th World Meeting on Pharmaceutics and Biopharmaceutics, Istambul, Turkey."},{"issue":"5","key":"10.1016\/B978-0-323-46142-9.00030-X_bib0100","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejps.2011.12.016","article-title":"Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)","volume":"45","author":"Doktorovova","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0105","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3109\/10837450.2013.840846","article-title":"Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying","volume":"19","author":"Doktorovova","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","article-title":"Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers\u2014a systematic review of in vitro data","volume":"87","author":"Doktorovova","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3109\/03639045.2014.956111","article-title":"Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance","volume":"41","author":"Dolatabadi","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpb.2008.11.012","article-title":"Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization","volume":"72","author":"Dong","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(96)01559-3","article-title":"Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport","volume":"45","author":"Dreher","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejpb.2014.06.011","article-title":"Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs","volume":"88","author":"Fan","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.colsurfb.2012.04.014","article-title":"Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process","volume":"100","author":"Fangueiro","year":"2012","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0135","unstructured":"Ferreira, S.F., Andreani, T., Fangueiro, J.F., Doktorovov\u00e1, S., Silva, A.M., Souto, E.B., 2012. \u201cPARSOL\u00ae MCX LOADED LIPID-SILICA NANOPARTICLES: AN INNOVATIVE SUNSCREEN APPROACH\u201d, 9th Central European Symposium of Pharmaceutical Technology, In 9th Central European Symposium of Pharmaceutical Technology, Dubrovnik, Croatia."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2015.07.013","article-title":"Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy","volume":"492","author":"Ferreira","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2013.03.061","article-title":"Controlling solid lipid nanoparticle adhesion by polyelectrolyte multilayer surface modifications","volume":"449","author":"Finke","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","article-title":"Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin","volume":"1","author":"Fonte","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN\u2122) dispersions","volume":"168","author":"Freitas","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0939-6411(97)00172-0","article-title":"Spray-drying of solid lipid nanoparticles (SLN TM)","volume":"46","author":"Freitas","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9055","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1016\/j.biomaterials.2008.07.008","article-title":"The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases","volume":"29","author":"Gao","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9060","first-page":"746325","article-title":"Evaluating cytotoxicity of hyaluronate targeted solid lipid nanoparticles of etoposide on SK-OV-3 Cells","volume":"2014","author":"Ghalaei","year":"2014","journal-title":"J. Drug Deliv."},{"issue":"1","key":"10.1016\/B978-0-323-46142-9.00030-X_bib0155","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2015.08.026","article-title":"Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery\u2014a comparison with solid lipid particles","volume":"495","author":"Gon\u00e7alves","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9070","first-page":"4107","article-title":"Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin","volume":"9","author":"Han","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/B978-0-323-46142-9.00030-X_bib0160","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3109\/10717544.2015.1065524","article-title":"A new approach for treatment of precancerous lesions with curcumin solid\u2013lipid nanoparticle-loaded gels: in vitro and clinical evaluation","volume":"23","author":"Hazzah","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0165","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1023\/A:1016090420759","article-title":"Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride","volume":"13","author":"Heiati","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9075","first-page":"312","article-title":"Effect of PEG2000 on drug delivery characterization from solid lipid nanoparticles","volume":"61","author":"Hong","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0170","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2174\/1568009614666141111154713","article-title":"Looking out for cancer stem cells\u2019 properties: the value-driving role of CD44 for personalized medicines","volume":"14","author":"Horta","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1166\/jbn.2008.021","article-title":"PEGylation of nanocarrier drug delivery systems: state of the art","volume":"4","author":"Howard","year":"2008","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0180","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/la104262k","article-title":"Physicochemical characterization of nanotemplate engineered solid lipid nanoparticles","volume":"27","author":"Howard","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: a new platform for nanomedicine","volume":"379","author":"Huynh","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","article-title":"Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes","volume":"105","author":"Ishida","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0195","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1021\/bm100754e","article-title":"Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers","volume":"11","author":"Ishihara","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jconrel.2010.09.003","article-title":"Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug","volume":"148","author":"Jain","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.colsurfb.2015.06.027","article-title":"Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin","volume":"134","author":"Jain","year":"2015","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02652040701799598","article-title":"Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting","volume":"25","author":"Jain","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2013.05.023","article-title":"A retinyl palmitate-loaded solid lipid nanoparticle system: effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo","volume":"452","author":"Jeon","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/13880209.2012.761245","article-title":"Dual ligands modified double targeted nano-system for liver targeted gene delivery","volume":"51","author":"Jing","year":"2012","journal-title":"Pharm. Biol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2003.11.012","article-title":"Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy","volume":"95","author":"Jores","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2006.07.021","article-title":"Development and characterisation of chitosan nanoparticles for siRNA delivery","volume":"115","author":"Katas","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2014.08.008","article-title":"Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants","volume":"474","author":"Keck","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/B978-0-323-46142-9.00030-X_bib9105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03639045.2015.1040414","article-title":"Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation","volume":"42","author":"Khan","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2010.12.036","article-title":"Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure","volume":"406","author":"Kovacevic","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0225","first-page":"206","article-title":"Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles","volume":"365","author":"Kuo","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.colsurfb.2009.04.004","article-title":"Impact of arginine-modified solid lipid nanoparticles on the membrane charge of human brain-microvascular endothelial cells","volume":"72","author":"Kuo","year":"2009","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0230","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cyto.10124","article-title":"Development and characterization of Ni-NTA-bearing microspheres","volume":"48","author":"Lauer","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0235","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1016\/j.biomaterials.2006.04.029","article-title":"High efficiency gene transfer using chitosan\/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation","volume":"27","author":"Lavertu","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9120","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.biomaterials.2007.01.014","article-title":"Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles","volume":"28","author":"Lee","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/10611860801902351","article-title":"Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate","volume":"16","author":"Lian","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2010.06.030","article-title":"Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers","volume":"397","author":"Liu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.07.019","article-title":"Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin","volume":"419","author":"Liu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","article-title":"Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system","volume":"403","author":"Luo","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carbpol.2014.12.084","article-title":"Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake","volume":"122","author":"Luo","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1166\/jbn.2009.1021","article-title":"Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia","volume":"5","author":"Ma","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9150","first-page":"39","article-title":"Body distribution and stability studies on mitoxantrone loaded solid lipid nanoparticles conjugated with concanavalina","volume":"2","author":"Mahor","year":"2010","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","article-title":"Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies","volume":"439","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles\u2014production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18433\/J3XK53","article-title":"Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route","volume":"13","author":"Mishra","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157016311796799062","article-title":"20\u00a0years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications","volume":"8","author":"Muller","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9160","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.colsurfb.2014.09.062","article-title":"Surface engineered nanostructured lipid carriers for targeting MDR tumor: part I. Synthesis, characterization and in vitro investigation","volume":"123","author":"Negi","year":"2014","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9165","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.colsurfb.2014.09.061","article-title":"Surface engineered nanostructured lipid carriers for targeting MDR tumor: part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies","volume":"123","author":"Negi","year":"2014","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2014.10.004","article-title":"Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application","volume":"477","author":"Nnamani","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0275","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijpharm.2011.12.011","article-title":"Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles","volume":"423","author":"Noack","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1166\/jbn.2007.007","article-title":"Cationic nanoparticles for delivery of CpG oligodeoxynucleotide and ovalbumin: in vitro and in vivo assessment","volume":"3","author":"Patel","year":"2007","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejpb.2014.05.019","article-title":"Montelukast-loaded nanostructured lipid carriers: part I Oral bioavailability improvement","volume":"88","author":"Patil-Gadhe","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0280","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.biomaterials.2010.03.010","article-title":"Translocation of cell penetrating peptide engrafted nanoparticles across skin layers","volume":"31","author":"Patlolla","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2005.09.003","article-title":"Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands","volume":"62","author":"Pedersen","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0290","series-title":"Surfactants and Interfacial Phenomena","author":"Rosen","year":"2004"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9180","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3109\/03639045.2014.891130","article-title":"Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel","volume":"41","author":"Sahu","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.colsurfb.2014.06.045","article-title":"Influence of surfactant composition on physical and oxidative stability of Quillaja saponin-stabilized lipid particles with encapsulated \u03c9-3 fish oil","volume":"122","author":"Salminen","year":"2014","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9190","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.foodchem.2015.06.054","article-title":"Influence of encapsulated functional lipids on crystal structure and chemical stability in solid lipid nanoparticles: Towards bioactive-based design of delivery systems","volume":"190","author":"Salminen","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpb.2012.11.022","article-title":"Wound dressings based on silver sulfadiazine SLN for tissue repairing","volume":"84","author":"Sandri","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcis.2009.06.033","article-title":"Influence of hydrophilic surfactants on the properties of multiple W\/O\/W emulsions","volume":"338","author":"Schmidts","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2010.07.037","article-title":"Development of multiple W\/O\/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability","volume":"398","author":"Schmidts","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2005.03.006","article-title":"Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier","volume":"61","author":"Schubert","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0315","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejps.2005.10.004","article-title":"Structural investigations on lipid nanoparticles containing high amounts of lecithin","volume":"27","author":"Schubert","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2012.08.003","article-title":"Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties","volume":"437","author":"Schwarz","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15415\/jptrm.2013.11004","article-title":"Surfactants: Pharmaceutical and medicinal aspects","volume":"1","author":"Sekhon","year":"2013","journal-title":"J. Pharm. Technol. Res. Manage."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.colsurfb.2011.03.029","article-title":"Polymorphism, crystallinity and hydrophilic\u2013lipophilic balance of stearic acid and stearic acid-capric\/caprylic triglyceride matrices for production of stable nanoparticles","volume":"86","author":"Severino","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0335","doi-asserted-by":"crossref","first-page":"750891","DOI":"10.1155\/2012\/750891","article-title":"Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery","volume":"2012","author":"Severino","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0340","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jconrel.2012.05.011","article-title":"Enhanced skin permeation using polyarginine modified nanostructured lipid carriers","volume":"161","author":"Shah","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-983X.1000105","article-title":"Preparation, characterization and cell based delivery of stavudine surface modified lipid nanoparticles","volume":"2","author":"Shegokar","year":"2012","journal-title":"J. Nanomed. Biother. Discov."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0345","first-page":"1000105","article-title":"Preparation, characterization and cell based delivery of stavudine surface modified lipid nanoparticles","volume":"2","author":"Shegokar","year":"2012","journal-title":"Nanomed. Biother. Discov."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-983X.1000105","article-title":"Preparation, Characterization and Cell Based Delivery of Stavudine Surface Modified Lipid Nanoparticles","volume":"2","author":"Shegokar","year":"2012","journal-title":"J. Nanomed. Biother. Discov."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0355","unstructured":"Shegokar R., Singh K.K., M\u00fcller, R.H., 2009. Cationic Nanostructured Lipid carriers (NLC) for Mucosal Drug Delivery. 5th German-Polish Symposium on New Challenges for Pharmaceutical Sciences, Poland."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0360","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.nano.2010.10.012","article-title":"In vitro protein adsorption studies on nevirapine nanosuspensions for HIV\/AIDS chemotherapy","volume":"7","author":"Shegokar","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0365","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijpharm.2010.08.014","article-title":"Production & stability of stavudine solid lipid nanoparticles\u2014from lab to industrial scale","volume":"416","author":"Shegokar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0370","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2012.04.050","article-title":"Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI\/ADR-RES)","volume":"431","author":"Siddiqui","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0375","first-page":"P443","article-title":"Conversion of stavudine lipid nanoparticles into dry powder","volume":"2","author":"Singh","year":"2011","journal-title":"Int. J. Pharm. Biosci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9205","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11095-014-1572-3","article-title":"Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery","volume":"32","author":"Song","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0380","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0975-7406.124309","article-title":"Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis","volume":"6","author":"Soni","year":"2014","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1773-2247(11)50005-X","article-title":"Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations","volume":"21","author":"Souto","year":"2011","journal-title":"J. Drug Del. Sci. Tech."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0390","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1773-2247(11)50005-X","article-title":"Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations","volume":"21","author":"Souto","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9210","doi-asserted-by":"crossref","first-page":"105101","DOI":"10.1088\/0957-4484\/25\/10\/105101","article-title":"Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles","volume":"25","author":"Surajit","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9215","doi-asserted-by":"crossref","first-page":"105102","DOI":"10.1088\/0957-4484\/25\/10\/105102","article-title":"Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations","volume":"25","author":"Surajit","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0395","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2004.02.029","article-title":"Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes","volume":"97","author":"Tabatt","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0400","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2014.12.047","article-title":"Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference","volume":"478","author":"Torrecilla","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nano.2012.03.003","article-title":"Increased brain uptake of docetaxel and ketoconazole loaded folate grafted solid lipid nanoparticles","volume":"9","author":"Venishetty","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9230","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nano.2012.08.004","article-title":"Beta-hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain","volume":"9","author":"Venishetty","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejpb.2007.02.006","article-title":"Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid","volume":"67","author":"Vighi","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0415","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2010.01.030","article-title":"pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles","volume":"389","author":"Vighi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.colsurfb.2015.04.049","article-title":"Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier","volume":"131","author":"Vyas","year":"2015","journal-title":"Colloids Surf. B Biointerface"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9245","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3109\/03639045.2014.938082","article-title":"PEGylated nanostructured lipid carriers (PEG\u2013NLC) as a novel drug delivery system for biochanin A","volume":"41","author":"Wang","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9240","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/10717540903580176","article-title":"Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability","volume":"17","author":"Wang","year":"2010","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/B978-0-323-46142-9.00030-X_bib0420","first-page":"37","article-title":"Fixed-oil excipient monographs: development of usp fixed-oil reference standards","volume":"37","author":"Wendt","year":"2013","journal-title":"Pharm. Technol."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0430","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0425","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(97)04890-4","article-title":"Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles","volume":"151","author":"Westesen","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0435","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.carbpol.2011.01.037","article-title":"Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin","volume":"84","author":"Ying","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7150\/thno.3463","article-title":"Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy","volume":"2","author":"Yu","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9255","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"Zara","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0445","first-page":"1049","article-title":"Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/B978-0-323-46142-9.00030-X_bib9260","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3109\/10717544.2015.1054052","article-title":"Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy","volume":"23","author":"Zhang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2013.04.030","article-title":"Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers","volume":"450","author":"Zhao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0450","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejpb.2012.04.023","article-title":"A frustrating problem: accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats","volume":"81","author":"Zhao","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib0455","first-page":"2891","article-title":"Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles","volume":"7","author":"Zhao","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9270","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1007\/s11095-014-1320-8","article-title":"Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles","volume":"31","author":"Zheng","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-323-46142-9.00030-X_bib9275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijpharm.2014.12.068","article-title":"Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption","volume":"479","author":"Zhou","year":"2015","journal-title":"Int. J. Pharm."}],"container-title":["Nanostructures for Novel Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978032346142900030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978032346142900030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T10:43:38Z","timestamp":1601721818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B978032346142900030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780323461429"],"references-count":133,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-46142-9.00030-x","relation":{},"subject":[],"published":{"date-parts":[[2017]]}}}